1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Peripheral Primitive Neuroectodermal Tumor: new trials by email Literature Review of Peripheral Primitive Neuroectodermal Tumor trials Research Report on Peripheral Primitive Neuroectodermal Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors Lutetium Lu 177-Edotreotide, Amino Acid Solution - Somatostatin Receptor Positive, NETs | Phase 1 | Recruiting | ITM Solucin GmbH | 20 | 2025-09-26 | 2026-10-27 |
Central Nervous System Neoplasms (1) · Gastro-enteropancreatic neuroendocrine tumor (1) · Lymphoma (1) · Neuroectodermal Tumors, Primitive, Peripheral (1) · Neuroendocrine Tumors (1) · Rhabdomyosarcoma (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Myosarcoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Muscle Tissue (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1)
177Lu-octreotide, DOTA(0)-Tyr(3)- (1) · amino-acid, glucose, and electrolyte solution (1)
ITM Solucin GmbH (1)
France (1) · Spain (1) · United States (1)